Developing New Approaches To Treating Lyme Disease

and Prof Lewis research  on persister cells of Borrelia. 
http://lookingatlyme.blogspot.co.uk/2015/05/borrelia-burgdorferi-lyme-disease-forms.html

 Dr Horowitz has been working closely with these doctors to try to develop new approaches and claims to be having some success such that trials are due to be done shortly.
An earlier post on Dr Horowitz 
http://lookingatlyme.blogspot.co.uk/2013/10/infection-inflammation-immune.html

So I was very interested to read a summary about a recent presentation from Dr Horowitz at a weekend conference, this is discussed at length on the Lymewhisperers blog 
http://lymewhisperer.com/2015/12/13/kripalu-closing-in-on-the-8/

‘Dr. Horowitz and Ying Zhang from John Hopkins, it seems, are on the verge of a breakthrough. Using mycobacterium drugs–like those used in leprosy and tuberculosis–in hope of cleverly and mercilessily attack the four main persisters: Borrelia, Babesia, Bartonella and mycoplasma. As Dr. Horowitz explains, he is typically successful in getting 92% of his patients better. But there is an “8%” that are the most difficult to treat. Could this breakthrough break the code for closing in on the 8% of people that are most difficult to get better? It could. I’ll never forget those chilling yet cheerful words: “We are closing in on the 8%,” Dr. Horowitz whispered.’

Go to the above link to read more and thank you to Lymewhisperer for sharing this important information with us.